SOARES, M. G. S.; SOARES, MARIA GABRYELLE DA SILVA; http://lattes.cnpq.br/9135649846746772; SOARES, Maria Gabryelle da Silva.
Resumo:
The pandemic caused by the new coronavirus has alarmingly affected millions of people,
leading to death in a considerable part of the population. Among the main factors for worse
clinical outcomes of COVID-19 infection, is diabetes mellitus, characterized by
increase in glycemic levels due to disturbances in the production and/or action of insulin in
cells. Due to the high risk of contagion and the lack of clarity of information,
especially at the beginning of the pandemic, social isolation came as a consequence, in
order to prevent the spread of the virus, harming social contact and access to
health services. Given these conditions, care for diabetic patients has become
if even more important and essential in the course of the pandemic, to avoid aggravations or even
even reduce mortality in this population. It was proposed in this study to analyze the
management of the general care of individuals with diabetes mellitus during the pandemic of
COVID-19, from the literature. This is an integrative literature review, based on
of articles available on digital platforms: PubMed, MEDLINE and SciELO, in
Portuguese, English and Spanish languages. The descriptors used to search for articles
were: diabetes mellitus, COVID-19 and hypoglycemic drugs, with a focus on GLP-1. the articles,
once located, a total of 10 were included after reading the titles, followed by
through the abstracts and, at the end, its full reading, going through the inclusion criteria and
proposed exclusion. Multiple mechanisms may explain the increased susceptibility
of diabetics to respiratory infections, one of them is the overexpression of the
cell membrane that serves as a receptor for the virus and an inflammatory response
exacerbated, increasing the risk of decompensation and the onset of seizures
hyperglycemic. Other mechanisms are given by the increase in binding affinity
between the protein and the virus and the reduction of the function of the defense cells. So, the
Glycemic control is crucial for disease control and consequent risk reduction
of criticality in cases of SARS-CoV-2 infection.treatment routines and
care of diabetic patients, was greatly affected during the peak of the pandemic, with
treatment interruptions at health centers, limited access to medicines and
other applied technologies. Care strategies have been tried and
adopted during this period, as is the case of the GLP1-RAs and their possible anti-
inflammatory conditions, in addition to alternative care therapies, such as teleservices. THE
From the data obtained, greater susceptibility was seen in diabetics to higher
complications of COVID-19, the positive action of some oral antidiabetic drugs and also the
insulin, depending on the severity of the infection, in addition to positive impacts of
care with guidelines on glycemic control, specialized care and
other support measures, such as psychological support, aimed at the treatment of
of DM, reinforcing that more research and prospective studies are carried out to
the discovery and proof of more care therapies against COVID-19.